Validation of the Italian version of carers' quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy.


Journal

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 01 04 2019
accepted: 20 05 2019
pubmed: 14 6 2019
medline: 8 2 2020
entrez: 14 6 2019
Statut: ppublish

Résumé

Progressive supranuclear palsy (PSP) is a rare, rapidly progressive, neurodegenerative disease characterized by falls and ocular movement disturbances. Caring for a partner or relative who suffers from PSP entails a strenuous and demanding task, usually lasting for years that affects carers' everyday life routines and emotional and social well-being. The 26-item Parkinsonism Carers QoL (PQoL Carer) is a self-administered, concise instrument evaluating the quality of life of caregivers of patients with atypical parkinsonism (both PSP and multiple system atrophy). Here, the PQoL Carer was translated into Italian and validated in 162 carers of PSP patients (54.3% women; mean age (standard deviation), 62.4 (15.4)) diagnosed according to the Movement Disorder Society criteria and recruited in 16 third-level movement disorders centers participating in the Neurecanet project. The mean PQoL total score was 40.66 ± 19.46. The internal consistency was excellent (Cronbach's alpha = 0.941); corrected item-total correlation was > 0.40 for all the items. A correlation with other health-related quality of life measures as well as with behavioral assessments was shown suggesting adequate convergent validity of the scale. PQoL also correlated with patients' severity of disease. The discriminant validity of the scale was evidenced by its capacity to differentiate between carers with varying levels of self-reported health (p < 0.001). In conclusion, the Italian version of the PQoL Carer is an easy, consistent, and valid tool for the assessment of the quality of life in carers of PSP patients.

Identifiants

pubmed: 31190253
doi: 10.1007/s10072-019-03944-x
pii: 10.1007/s10072-019-03944-x
doi:

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2163-2169

Références

Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
Qual Life Res. 2002 May;11(3):193-205
pubmed: 12074258
Brain. 2007 Jun;130(Pt 6):1552-65
pubmed: 17405767
Qual Life Res. 2016 Jan;25(1):81-8
pubmed: 26264781
Mov Disord. 2017 Mar;32(3):463-466
pubmed: 27873351
Parkinsonism Relat Disord. 2017 Jan;34:7-14
pubmed: 28341224
Mov Disord. 2017 Jun;32(6):853-864
pubmed: 28467028
Lancet Neurol. 2017 Jul;16(7):552-563
pubmed: 28653647
Mov Disord. 2018 Aug;33(8):1361-1365
pubmed: 29984518
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Neurology. 1998 Nov;51(5):1303-9
pubmed: 9818850

Auteurs

Marina Picillo (M)

Center for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Odontoiatry, University of Salerno, 84131, Salerno, Italy.

Sofia Cuoco (S)

Center for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Odontoiatry, University of Salerno, 84131, Salerno, Italy.

Marianna Amboni (M)

Center for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Odontoiatry, University of Salerno, 84131, Salerno, Italy.

Francesco Paolo Bonifacio (FP)

Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.

Antonino Bruno (A)

Dipartimento di Medicina Clinica e Sperimentale, Università di Pisa, Pisa, Italy.

Fabio Bruschi (F)

Parkinson's Disease and Movement Disorders Unit, IRCCS Mondino Foundation, Pavia, Italy.

Arianna Cappiello (A)

Center for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Odontoiatry, University of Salerno, 84131, Salerno, Italy.

Rosa De Micco (R)

Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.

Anna De Rosa (A)

Department of Neurosciences and Reproductive and Odontostomatological Sciences, Federico II University, Naples, Italy.

Francesca Di Biasio (F)

IRCCS Policlinico San Martino, Genoa, Italy.

Francesca Elifani (F)

IRCCS Neuromed, Pozzilli, Italy.

Roberto Erro (R)

Center for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Odontoiatry, University of Salerno, 84131, Salerno, Italy.

Margherita Fabbri (M)

Department of Neuroscience "Rita Levi Montalcini", University of Turin, Via Cherasco 15, 10124, Torino, Italy.

Marika Falla (M)

Department of Neurology, General Hospital of Bolzano, Bolzano, Italy.
CIMec and CeRIN, University of Trento, Rovereto, Italy.

Giulia Franco (G)

IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Dino Ferrari Center, Neuroscience Section, Department of Pathophysiology and Transplantation, University of Milan, 20122, Milan, Italy.

Daniela Frosini (D)

Dipartimento di Medicina Clinica e Sperimentale, Università di Pisa, Pisa, Italy.

Sebastiano Galantucci (S)

Dipartimento Neurologico, IRCCS Ospedale San Raffaele - Milano, Milan, Italy.

Giulia Lazzeri (G)

IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Dino Ferrari Center, Neuroscience Section, Department of Pathophysiology and Transplantation, University of Milan, 20122, Milan, Italy.

Luca Magistrelli (L)

Movement Disorders Centre, Neurology Unit, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
PhD Program in Clinical and Experimental Medicine and Medical Humanities, University of Insubria, Varese, Italy.

Maria Chiara Malaguti (MC)

UO Neurologia, Ospedale Santa Chiara Trento, Azienda Provinciale per i Servizi Sanitari Provincia Autonoma di Trento, Trento, Italy.

Anna Vera Milner (AV)

Movement Disorders Centre, Neurology Unit, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.

Brigida Minafra (B)

Parkinson's Disease and Movement Disorders Unit, IRCCS Mondino Foundation, Pavia, Italy.

Enrica Olivola (E)

IRCCS Neuromed, Pozzilli, Italy.

Andrea Pilotto (A)

Centre for Neurodegenerative Disorders, Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

Cristina Rascunà (C)

Department G.F. Ingrassia, Section of Neurosciences, University of Catania, Catania, Italy.

Maria Cristina Rizzetti (MC)

S. Isidoro Hospital - FERB Onlus, Trescore Balneario, Bergamo, Italy.

Tommaso Schirinzi (T)

Centro Parkinson, Dip. Medicina dei Sistemi, Policlinico Tor Vergata, Rome, Italy.

Barbara Borroni (B)

Centre for Neurodegenerative Disorders, Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

Roberto Ceravolo (R)

Dipartimento di Medicina Clinica e Sperimentale, Università di Pisa, Pisa, Italy.

Alessio Di Fonzo (A)

IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Dino Ferrari Center, Neuroscience Section, Department of Pathophysiology and Transplantation, University of Milan, 20122, Milan, Italy.

Leonardo Lopiano (L)

Department of Neuroscience "Rita Levi Montalcini", University of Turin, Via Cherasco 15, 10124, Torino, Italy.

Roberta Marchese (R)

IRCCS Policlinico San Martino, Genoa, Italy.

Nicola B Mercuri (NB)

Centro Parkinson, Dip. Medicina dei Sistemi, Policlinico Tor Vergata, Rome, Italy.

Nicola Modugno (N)

IRCCS Neuromed, Pozzilli, Italy.

Alessandra Nicoletti (A)

Department G.F. Ingrassia, Section of Neurosciences, University of Catania, Catania, Italy.

Alessandro Padovani (A)

Centre for Neurodegenerative Disorders, Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

Gabriella Santangelo (G)

Department of Psychology, University of Campania "Luigi Vanvitelli", Viale Ellittico 31, 81100, Caserta, Italy.

Alessandro Stefani (A)

Centro Parkinson, Dip. Medicina dei Sistemi, Policlinico Tor Vergata, Rome, Italy.

Alessandro Tessitore (A)

Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.

Maria Antonietta Volontè (MA)

Dipartimento Neurologico, IRCCS Ospedale San Raffaele - Milano, Milan, Italy.

Roberta Zangaglia (R)

Parkinson's Disease and Movement Disorders Unit, IRCCS Mondino Foundation, Pavia, Italy.

Mario Zappia (M)

Department G.F. Ingrassia, Section of Neurosciences, University of Catania, Catania, Italy.

Paolo Barone (P)

Center for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Odontoiatry, University of Salerno, 84131, Salerno, Italy. pbarone@unisa.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH